Ecto-5' -nucleotidase (ecto-5' -nt) is a differentiation antigen expressed on subpopulations of human T and B cells. The majority of ecto-5' -NT activity can be released from the lymphoycte surface by phosphatidylinositol-specific phospholipase C (PI-PLC), suggesting that at least a portion of this enzyme is attached to the membrane by covalent linkage to PI or a closely-related structure. Recent experiments in our laboratory suggest that ecto-5' -NT, like other PI-linked T cell surface antigens including Thy-1, T cell activating protein, and Rt-6, may be involved in transmembrane signaling, since anti-5' -NT antibodies, in combination with submitogenic doses of phorbol esters, can drive human T cells to proliferate. The purpose of the proposed research is threefold: 1) to understand how the expression of ecto-5' -NT is regulated during human lymphocyte ontogeny and differentiation, 2) to delineate the molecular mechanism(s) responsible for reduced ecto-5' -NT expression in lymphocytes of patients with immunodeficiency diseases, and 3) to determine whether the PI-containing membrane anchoring structure of ecto-5' -NT is necessary for its proposed function in transmembrane signaling. Therefore, we plan to clone the gene for 5' -NT in order to develop probes which can be used to study the transcriptional control of ecto-5 -NT expression and the structure of the 5' -NT gene, including regulatory sequences. 5' -NT specific mRNA from ecto-5' -NT positive and negative T and B cells from normal individuals, as well as from lymphocytes of immunodeficient patients with ecto- 5 -NT deficiency, will be characterized by Northern blotting. We will attempt to identify cDNAs corresponding to a PI-linked form of the enzyme, an integral membrane form, and perhaps a soluble form. We will then determine whether ecto-5 -NT deficiency results from a failure to transcribe the 5'-NT gene or Whether a form of the enzyme is synthesized which cannot be inserted into the membrane. We will also transfect the ecto-5 -NT- human T cell line Jurkat with 5'-NT cDNAs corresponding to PI-linked and integral membrane forms of 5'-NT. In order to determine whether the PI anchor of 5' -NT is necessary for the enzyme to function in signal transduction, both types of transfectants will be tested for the ability to secrete IL-2 after stimulation with anti-5 -NT antibodies and phorbol esters. The results of these experiments will not only give insight into the mechanisms controlling ecto-5'-NT expression during lymphocyte differentiation, but will also increase our understanding of the function of this interesting enzyme and the significance of reduced ecto-5 -NT expression on lymphocytes of immunodeficient patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018220-09
Application #
3127761
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1989-09-01
Project End
1993-08-31
Budget Start
1990-09-01
Budget End
1991-08-31
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
937727907
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
de Leve, Simone; Wirsdörfer, Florian; Cappuccini, Federica et al. (2017) Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs. FASEB J 31:2869-2880
Wirsdörfer, Florian; de Leve, Simone; Cappuccini, Federica et al. (2016) Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis. Cancer Res 76:3045-56
Yago, Tadayuki; Tsukamoto, Hiroki; Liu, Zhenghui et al. (2015) Multi-Inhibitory Effects of A2A Adenosine Receptor Signaling on Neutrophil Adhesion Under Flow. J Immunol 195:3880-9
Coffey, Francis; Lee, Sang-Yun; Buus, Terkild B et al. (2014) The TCR ligand-inducible expression of CD73 marks ?? lineage commitment and a metastable intermediate in effector specification. J Exp Med 211:329-43
Qin, Lei; Thompson, Linda F; Kuzel, Timothy M et al. (2014) Requirement of NK cells for selective A2A receptor blockade to suppress CD73+ tumor metastasis. Immunotherapy 6:19-21
Thompson, Linda F (2013) Editorial: CD73 deficiency and immune dysregulation in HIV infection: cause or effect? J Leukoc Biol 94:545-7
Tsukamoto, Hiroki; Chernogorova, Petya; Ayata, Korcan et al. (2012) Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease. Blood 119:4554-64
Blackburn, Michael R; Thompson, Linda F (2012) Adenosine deaminase deficiency: unanticipated benefits from the study of a rare immunodeficiency. J Immunol 188:933-5
Wang, Long; Fan, Jie; Thompson, Linda F et al. (2011) CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest 121:2371-82
Haskó, György; Csóka, Balázs; Koscsó, Balázs et al. (2011) Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis. J Immunol 187:4256-67

Showing the most recent 10 out of 64 publications